Search by Drug Name or NDC

NDC 70436-0104-05 Ranolazine 1000 mg/1 Details

Ranolazine 1000 mg/1

Ranolazine is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Slate Run Pharmaceuticals. The primary component is RANOLAZINE.

MedlinePlus Drug Summary

Ranolazine is used alone or with other medications to treat chronic angina (ongoing chest pain or pressure that is felt when the heart does not get enough oxygen). Ranolazine is in a class of medications called anti-anginals. The exact way that ranolazine works is not known at this time.

Related Packages: 70436-0104-05
Last Updated: 05/05/2024
MedLinePlus Full Drug Details: Ranolazine

Product Information

NDC	70436-0104
Product ID	70436-104_7610b62e-bdf5-47bd-8bbf-37654ab727bf
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Ranolazine
Proprietary Name Suffix	n/a
Non-Proprietary Name	ranolazine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	1000
Active Ingredient Units	mg/1
Substance Name	RANOLAZINE
Labeler Name	Slate Run Pharmaceuticals
Pharmaceutical Class	Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA213085
Listing Certified Through	2024-12-31

Package

NDC 70436-0104-05 (70436010405)

Pricing Information	N/A
NDC Package Code	70436-104-05
Billing NDC	70436010405
Package	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70436-104-05)
Marketing Start Date	2023-07-25
NDC Exclude Flag	N